CatalystWireBeta

MicroSalt placement of SaltMe Low Sodium Crisps

In brief · summary, not quotable

No summary for this filing – the full text is below.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your TEK notes

Tekcapital Plc (AIM: TEK) the UK intellectual property investment group focused on creating valuable products that can improve people's lives, is pleased to announce that Longs Drugs a leading drug store chain in Hawaii has committed to place MicroSalt's SaltMe! Crisps in their stores.

MicroSalt® provides a much-needed option that allows food manufacturers and consumers to slash the sodium content of their food without impacting the flavour. With 31% of adults worldwide suffering from high blood pressure and other cardiovascular diseases - and with efforts mounting around the globe to lower the sodium content in prepared and packaged foods - MicroSalt® is offering a truly timely solution.

"We are very excited about the placement of our SaltMe Low Sodium Crisps with the Longs Drug Chain. Excess sodium consumption is one of the leading contributors to hypertension and heart disease. Placements like this are the best way to provide consumers with great tasting, healthy products with less sodium," said Rick Guiney, CEO of MicroSalt®.

About Longs Drugs

Longs Drugs is an American drug store chain owned by parent company CVS Health, with approximately 70 drugstores throughout the state of Hawaii. Longs Drugs was acquired by parent company CVS Health in 2008. To learn more please visit https://en.wikipedia.org/wiki/Longs_Drugs.

About MicroSalt®plc

MicroSalt, is the developer and manufacturer of a proprietary low-sodium salt called MicroSalt®. We are passionate about improving peoples' lives with better-for-you seasonings and snacks by taking the lead in the industry by providing the best low-sodium salt solution, based on the mechanical transformation of the salt particle itself. This solution is the only one that delivers real salt flavour because it is salt. Our new patented technology produces salt crystals that are approximately one hundred times smaller than typical table salt, delivering a powerful saltiness as the micro-grains dissolve in the mouth, with approximately 50% less sodium consumption. Additionally, the ultra-small particle size enhances product adhesion, which reduces waste and provides improved flavor consistency. MicroSalt® and SaltMe® are registered trademarks of MicroSalt Inc.

To learn more about MicroSalt please visit https://www.microsalt.co

Tekcapital owns approximately 87% of the share capital of MicroSalt plc and 92% of MicroSalt Inc. its U.S. subsidiary.

Clifford M. Gross, Ph.D.

SP Angel Corporate Finance LLP (Nominated Adviser and Broker)+44 (0) 20 3470 0470

Richard Morrison / Charlie Bouverat (Corporate Finance) Rob Rees (Corporate Broking)

Flagstaff Strategic and Investor Communications +44 (0)207 129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note